Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia

Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specific neut...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Emerging infectious diseases 2021-05, Vol.27 (5), p.1472-1476
Hauptverfasser: Alshukairi, Abeer N, Zhao, Jincun, Al-Mozaini, Maha A, Wang, Yanqun, Dada, Ashraf, Baharoon, Salim A, Alfaraj, Sara, Ahmed, Waleed A, Enani, Mushira A, Elzein, Fatehi E, Eltayeb, Nazik, Layqah, Laila, El-Saed, Aiman, Bahaudden, Husam A, Haseeb, Abdul, El-Kafrawy, Sherif A, Hassan, Ahmed M, Siddiq, Najlaa A, Alsharif, Ibtihaj, Qushmaq, Isamel, Azhar, Esam I, Perlman, Stanley, Memish, Ziad A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specific neutralizing antibodies were detected for 6 years postinfection.
ISSN:1080-6040
1080-6059
DOI:10.3201/eid2705.204056